<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04918134</url>
  </required_header>
  <id_info>
    <org_study_id>2021-SDU-QILU-G002</org_study_id>
    <nct_id>NCT04918134</nct_id>
  </id_info>
  <brief_title>Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province</brief_title>
  <official_title>Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helicobacter pylori can lead to a variety of digestive system diseases.The eradication of&#xD;
      Helicobacter pylori plays an importment role for the treatment of gastrointestinal ulcer and&#xD;
      prevention of gastric cancer .Compared with other countries and regions in the world, the&#xD;
      infection rate of Helicobacter pylori in China can reach more than 50%. The non-standard&#xD;
      diagnosis and treatment of Helicobacter pylori greatly reduces its eradication rate and&#xD;
      increases its drug resistance.Therefore, it is very important to strengthen the&#xD;
      standardization of diagnosis and treatment to improve the eradication rate.&#xD;
&#xD;
      The purpose of this study is to investigate the diagnosis and treatment status of&#xD;
      Helicobacter pylori among gastroenterologists in general hospitals in Shandong Province.It&#xD;
      can help us to understand the actual situation of diagnosis and treatment of Helicobacter&#xD;
      pylori in hospitals at all levels, and to provide targeted diagnosis and treatment training&#xD;
      for doctors.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 10, 2021</start_date>
  <completion_date type="Actual">October 7, 2021</completion_date>
  <primary_completion_date type="Actual">August 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the results of the questionnaires</measure>
    <time_frame>2 months</time_frame>
    <description>the results of each question of the questionnaires</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Stratified sampling was carried out from all the secondary and tertiary general hospitals&#xD;
        in Shandong province, and 120 hospitals were selected.Exclude those without&#xD;
        gastroenterology department and those that refused to sign the informed consent, and all&#xD;
        gastroenterologists in the hospitals were investigated.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All the gastroenterologists in secondary and tertiary general hospitals of Shandong&#xD;
             province&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A hospital that does not include gastroenterology&#xD;
&#xD;
          -  Hospitals and gastroenterologists that refuse to sign informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Qilu hosipital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>257000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2021</study_first_posted>
  <last_update_submitted>October 10, 2021</last_update_submitted>
  <last_update_submitted_qc>October 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Xiuli Zuo</investigator_full_name>
    <investigator_title>Professor, Director of gastroenterology department of Qilu hospital</investigator_title>
  </responsible_party>
  <keyword>questionnaire</keyword>
  <keyword>Helicobacter Pylori Infection</keyword>
  <keyword>cross-sectional survey</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

